Using KHDC4 as a prognostic factor for PCa patients demonstrated that those with higher KHDC4 expression had a worse overall survival rate (p = 0.0015, HR = 14) and disease-free survival rate (p = 0.003, HR = 1.9) (Figure 1J). Here, KHDC4 is linked to posterior cortical atrophy.